Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

Clinical trial NCT02181738 · COMPLETED

Trial details

NCT number: NCT02181738
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Disease

Start date: 2014-08-12
Primary completion: 2017-08-31
Enrollment: 294

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.